KELLY EDWARDS: Open Payments
NPI 1285880724 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$277 in 15 payments from 10 companies in 2025. Trend: 2023 $699 · 2024 $507 · 2025 $277
Food & beverage: $277
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $48 |
| Astellas Pharma US Inc | 2 | $43 |
| Organon LLC | 2 | $39 |
| Hologic Sales and Service, LLC | 2 | $38 |
| Sage Therapeutics, LLC | 2 | $30 |
| ABBVIE INC. | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
| Evofem Biosciences, Inc. | 1 | $16 |
| Exeltis, USA Inc. | 1 | $16 |
| Dynavax Technologies Corporation | 1 | $10 |
Products named: Veozah, NEXPLANON, FLUENT FLUID MANAGEMENT SYSTEM, ZURZUVAE, LILETTA, MYFEMBREE, Phexxi, SLYND.
Industry payments across MO — which companies pay providers there.
